Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Medical device type testing, also known as type examination, is the conformity assessment process in which representative product samples are evaluated against national standards, industry standards, and registered product technical requirements to support regulatory registration. This technical guide explains the scope of type testing, applicable standards, sample categories, testing items, laboratory methods, and the practical process manufacturers follow when preparing a registration dossier.

Technical Overview

Medical device type testing, also referred to as type examination, is a conformity assessment activity in which representative samples of a finished medical device are subjected to laboratory testing to verify that the product conforms to applicable safety standards, performance criteria, and the manufacturer's declared product technical requirements. The resulting type test report is a core technical document in the registration dossier, particularly for Class II and Class III devices in jurisdictions such as China, where the process is administered under the regulatory framework of the National Medical Products Administration (NMPA).

The essential purpose of type testing is to confirm, through objective laboratory evidence, that the device design achieves an acceptable level of basic safety and essential performance. Samples must be representative of series production and must be manufactured under the manufacturer's quality management system, typically certified to ISO 13485. Testing is performed either by accredited third-party laboratories holding the appropriate qualifications or, where permitted under self-testing provisions, by manufacturers who can demonstrate the necessary testing capability in accordance with ISO/IEC 17025 principles.

The scope of testing is established through a standards applicability analysis that identifies mandatory national standards (GB series), medical device industry standards (YY/YY-T series), and relevant international standards published by ISO, IEC, and ASTM. Where no published standard exists for a specific characteristic, the device is verified against the manufacturer's own validated in-house test methods, which must be described in the product technical requirements.

Testing Samples

Sample planning is a critical early step in the type testing process. Submitted samples must be identical in design, materials, manufacturing process, and packaging to the product intended for series production. Sufficient quantities must be provided to cover destructive tests, repeat tests in case of nonconformity, and retention samples, and the sample inventory should be documented before submission.

Active Medical Devices

Active devices include electro-medical equipment such as patient monitors, electrocardiographs, ventilators, infusion and syringe pumps, electrosurgical units, therapeutic equipment, and diagnostic imaging systems. Samples must be submitted with all essential accessories, applied parts, power cords, interconnection cables, and the largest intended patient-connection configuration so that worst-case electrical and electromagnetic conditions can be evaluated.

Non-Active Medical Devices

Non-active devices cover orthopedic implants such as bone plates, bone screws, intramedullary nails, and joint prostheses, as well as surgical instruments, dental materials, and absorbable materials. These samples are typically subjected to static strength, fatigue, wear, and corrosion testing, for example bone plate bending per ASTM F382, torsional and axial testing of bone screws per ASTM F543, and spinal construct fatigue per ASTM F1717.

Sterile and Single-Use Devices

This category includes hypodermic syringes, needles, infusion sets, catheters, and other single-use products supplied sterile. Samples must be submitted in their final sterile barrier packaging, since packaging integrity, sterility, and shelf-life performance are integral parts of the type test program.

In Vitro Diagnostic Products

In vitro diagnostic devices include reagents, calibrators, control materials, and associated instruments. Type testing focuses on analytical performance characteristics such as accuracy, precision, linearity, analytical sensitivity, analytical specificity, and interference, verified against the product technical requirements using representative lots and reference materials.

Testing Items

The specific test program depends on the device classification, technology, and intended use. A typical type test portfolio for a medical device includes the following items, each mapped to a specific standard clause in the product technical requirements.

  • Performance testing of all functional characteristics declared in the product technical requirements, including measurement accuracy, alarm functions, and software-driven features.
  • Electrical safety testing per IEC 60601-1 and its Chinese counterpart GB 9706.1, including protection against electric shock, mechanical hazards, excessive temperatures, and inaccurate output, together with applicable particular standards of the IEC 60601-2 series.
  • Electromagnetic compatibility testing per IEC 60601-1-2 or YY 9706.102, covering conducted and radiated emissions as well as immunity to electrostatic discharge, radio-frequency fields, electrical fast transients, surges, and power-frequency magnetic fields.
  • Biological evaluation per the ISO 10993 series and GB/T 16886, typically including cytotoxicity, sensitization, and irritation testing, extended to hemocompatibility, genotoxicity, and subchronic toxicity for blood-contacting or implantable devices.
  • Sterility assurance and sterilization residual testing, referencing validated processes per ISO 11137 for radiation, ISO 11135 for ethylene oxide, and corresponding verification of residuals and pyrogen status.
  • Packaging and shelf-life evaluation per ISO 11607 and GB/T 19633, including seal strength, microbial barrier properties, and accelerated aging per ASTM F1980 supported by real-time aging data.
  • Environmental and transport conditioning per IEC 60068 and GB/T 14710, covering cold, dry heat, damp heat, vibration, and mechanical shock exposure followed by functional verification.
  • Usability documentation per IEC 62366-1 and software life-cycle documentation per IEC 62304, verified through dossier review and, where necessary, supplementary bench verification.
  • Chemical characterization of materials, including extractables and leachables studies for devices with patient or fluid contact.

Testing Methods

Type testing relies principally on standardized laboratory methods published by ISO, IEC, ASTM, and national standards bodies. Standard methods are applied exactly as written, including specified environmental conditions, instrumentation accuracy, test sequences, and acceptance criteria. Where a device characteristic has no published method, the laboratory verifies the manufacturer's method through method validation covering accuracy, precision, repeatability, and detection limits.

Test sequencing is an important technical consideration. For electrical safety programs, dielectric strength and leakage current measurements are performed after humidity preconditioning, and immunity tests are sequenced so that cumulative stress does not invalidate subsequent measurements. For implantable devices, fatigue tests are executed at worst-case load levels derived from risk analysis conducted per ISO 14971, and chemical tests use extraction conditions that simulate clinical exposure. All results are recorded against the specific clause of the product technical requirements so that conformity can be traced item by item.

Testing Process

The type testing workflow follows a structured sequence that minimizes delays and ensures the report is acceptable for registration review.

  • Applicability determination: confirming the mandatory and recommended standards applicable to the device classification and intended use, and finalizing the product technical requirements.
  • Contract and sample submission: signing the testing agreement, preparing the documented sample inventory, and submitting samples with technical documentation and operating instructions.
  • Laboratory testing: executing the agreed test program, with the laboratory issuing preliminary notices for any nonconforming items.
  • Nonconformity handling: investigating failures, implementing design or process corrections, and submitting replacement samples for the affected tests.
  • Report issuance: issuing the type test report with itemized results, standard references, sample descriptions, and test equipment identifications.

Applications

Type test reports serve multiple regulatory and commercial purposes throughout the product life cycle.

  • Registration submissions for Class II and Class III medical devices, where the report is a mandatory dossier element.
  • Registration renewal, where updated testing may be required to demonstrate conformity with revised national or industry standards.
  • Design change evaluation, where significant modifications to materials, components, software, or manufacturing processes trigger supplementary testing.
  • Tender and procurement qualification, in which purchasers require current evidence of standards conformity.
  • Support for export market access, where type test data provides the technical basis for documentation packages in other jurisdictions.
  • Internal quality planning, since the validated test items and acceptance criteria form the baseline for routine release testing.

FAQ

What is the difference between type testing and routine factory testing?

Type testing is a one-time or design-level verification performed on representative samples against the full set of applicable standards, whereas routine factory testing is a reduced, repeated verification performed on every production lot to confirm that manufacturing remains consistent with the qualified design.

How many samples are required for type testing?

Sample quantity depends on the test program. Destructive tests such as fatigue, sterility, and biocompatibility require dedicated samples, while electrical safety and EMC programs require a smaller number of units plus accessories. Laboratories typically publish itemized sample checklists, and manufacturers should add spare units for potential retesting.

How long does type testing take?

Simple devices with limited test programs may be completed within several weeks, while complex active devices requiring biocompatibility, packaging validation, and EMC testing commonly require several months. Early standards confirmation and complete documentation submission are the most effective ways to shorten the timeline.

Is the type test report subject to a validity period?

The report remains applicable as long as the device design, materials, manufacturing process, and product technical requirements do not change. Any significant change, or the revision of an applicable mandatory standard, may require supplementary or full retesting to maintain conformity evidence.

Can reports from laboratories outside the destination market be accepted?

Yes, in principle. Reports from accredited third-party laboratories can be accepted by regulatory authorities when the standards applied are technically equivalent to or not less stringent than the mandatory national standards, and when the laboratory's accreditation scope, typically under ISO/IEC 17025, covers the performed tests. The accepting authority retains the right to request supplementary verification.

Is manufacturer self-testing permitted?

Under current regulatory provisions, manufacturers may perform type testing themselves provided they have the verified personnel, facilities, and equipment corresponding to the test items, follow the declared product technical requirements, and maintain complete traceable records. Regulators verify self-testing capability during quality management system audits and on-site inspections.